IRINA AGOULNIK to Relaxin
This is a "connection" page, showing publications IRINA AGOULNIK has written about Relaxin.
Connection Strength
1.539
-
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology. Biochem Pharmacol. 2024 09; 227:116401.
Score: 0.864
-
Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2. Commun Biol. 2022 11 04; 5(1):1183.
Score: 0.193
-
Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists. Biochemistry. 2016 Mar 29; 55(12):1772-83.
Score: 0.121
-
Relaxin signaling in uterine fibroids. Ann N Y Acad Sci. 2009 Apr; 1160:374-8.
Score: 0.075
-
Relaxin/RXFP1 signaling in prostate cancer progression. Ann N Y Acad Sci. 2009 Apr; 1160:379-80.
Score: 0.075
-
Relaxin promotes prostate cancer progression. Clin Cancer Res. 2007 Mar 15; 13(6):1695-702.
Score: 0.065
-
Structure-Activity Relationship Studies toward the Optimization of First-In-Class Selective Small Molecule Agonists of the GPCR Relaxin/Insulin-like Family Peptide Receptor 2. J Med Chem. 2026 Mar 12; 69(5):5956-5985.
Score: 0.061
-
The role of relaxin in endometrial cancer. Cancer Biol Ther. 2006 Jan; 5(1):71-7.
Score: 0.060
-
Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1. Nat Commun. 2013; 4:1953.
Score: 0.024